State rheumatology society meetings provide many opportunities and benefits for rheumatology professionals, including networking and collaboration opportunities, skill enhancement, regulatory updates and leadership development.
Search results for: network
The 2023 ARP Merit Awards
SAN DIEGO—During ACR Convergence 2023 in November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the recipients of the ARP Merit Awards and ARP Master class, recognizing outstanding contributions to the field of rheumatology. The…
An Interview with Expert Clinician Dr. Fred Wigley
Rheumatologists who are outstanding researchers, educators and/or clinicians, who provide consistently exceptional care to patients, who have achieved a level of distinction in the field and who serve as role models for colleagues and trainees are highlighted in this recurring series. Fred Wigley, MD, MACR, is the Martha McCrory Professor of Medicine at the Johns…
Going Viral: How to Find & Engage Your Audience to Become a Podcast Celebrity
A panel of experts, including ACR on Air Host Jonathan Hausmann, MD, provided tips and insights into creating a podcast and engaging with an audience.
Advice for Authors: Editors Provide Tips & Tricks for Getting Your Work Published
Researchers and physician-scientists often need practical advice for getting their work published. Here are insights into how to select an appropriate publication, manage co-author relationships and more from a panel of experts in both rheumatology and publishing.
Heterogeneity in Lupus: Lessons from the Autoimmune Centers of Excellence
SAN DIEGO—The Autoimmunity Centers of Excellence (ACE) are a cooperative group funded by the National Institute of Allergy and Infectious Diseases (NIAID) that conduct basic and clinical research on autoimmune diseases.1 ACEs focus on treatment and prevention strategies that induce immune tolerance or modulate the immune system. The goal is to facilitate collaboration across clinicians…
Get AMPed: Understanding RA Through the Accelerating Medicines Partnership
SAN DIEGO—The Accelerating Medicines Partnership (AMP) is a public-private collaboration involving the National Institutes of Health (NIH), the U.S. Food & Drug Administration (FDA), multiple biopharmaceutical and life science companies, and nonprofit organizations, all joined together with the goal of transforming diagnosis and treatments for a multitude of diseases. One such condition that has been…
Pediatric Clinical Year in Review: 2023
SAN DIEGO—Too many excellent pediatric rheumatology studies to squeeze into one talk? What a good problem to have. Dr. Ardoin first highlighted baricitinib in juvenile idiopathic arthritis.
Life with Arthritis: Kaleb Michaud, PhD, Shares His Story
SAN DIEGO—“I’m going to get personal,” said Kaleb Michaud, PhD, in the ARP Distinguished Lecture at ACR Convergence 2023. When he was 3 years old, the young Kaleb was diagnosed him with juvenile rheumatoid arthritis (JRA).
President’s Perspective: Deborah Dyett Desir, MD, Assumes ACR Presidency
Deborah Dyett Desir, MD is the 87th ACR president and the first Black person elected to the position. In conversation with The Rheumatologist, this profile follows her career from academic research to private practice to Yale faculty & the ACR presidency.
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 98
- Next Page »